The Biology of Oligometastatic Prostate Cancer: A Different Beast than Polymetastatic Prostate Cancer.
Journal
European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
04
09
2018
revised:
11
11
2018
accepted:
26
11
2018
pubmed:
12
12
2018
medline:
18
12
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
The natural history and molecular biology of oligometastatic prostate cancer differentiate it from polymetastatic disease. Clinically, oligometastatic disease is also predictive and prognostic for different outcomes. Studies specific to this population are required to establish the benefits of intervention.
Identifiants
pubmed: 30527643
pii: S2405-4569(18)30372-9
doi: 10.1016/j.euf.2018.11.011
pii:
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
117-118Informations de copyright
Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.